Article
01 Jul 2025
HRSA Announces New Requirements For FQHCs To Provide Insulin And Epinephrine At Or Below 340B Price
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
06 Jun 2025
Federal District Court Upholds Authority Of HHS To Pre-Approve 340B Rebate Programs; HRSA Submits Proposed 340B Rebate Guidance
Article
27 Mar 2025
FDA's Semaglutide Shortage Resolution: Legal Implications And Risks For Compounding Pharmacies
Article
15 Nov 2024
California Votes To Impose 340B Spending Restrictions On Targeted 340B Providers